Rockwell Medical, Inc.
RMTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0.9% | -15% | -23.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 14.3% | 15.6% | 16.1% | 14.7% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -8.8% | -4.1% | -3.7% | 0.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11% | -9.3% | -8% | -3.1% |
| EPS Diluted | -0.05 | -0.044 | -0.044 | -0.023 |
| % Growth | -14.9% | 2% | -93% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |